Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AlgavitaBio is a French marine biotechnology company headquartered in Saint-Malo, specializing in the research, development, and production of high-value compounds derived from microalgae. The company utilizes advanced photobioreactor technology to cultivate specific microalgae strains under controlled conditions, ensuring high purity and concentration of bioactive metabolites. Their product portfolio targets the pharmaceutical, nutraceutical, and cosmetic industries, focusing on ingredients with antioxidant, anti-inflammatory, and skin-protective properties. AlgavitaBio's platform enables the sustainable production of complex molecules such as pigments, lipids, and polysaccharides that are difficult to synthesize chemically. The company is positioned as an innovation partner for firms seeking natural and sustainable bio-based ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AlgavitaBio.